NEW YORK (GenomeWeb News) — Belgium-based OncoMethylome Sciences has received a €1.95 million ($2.7 million) grant from the Belgian government to work on a collaborative project that will study women’s cancers and cancer vaccines, the company said today.
 
The four-year program, which includes research partners the University of Liege and GlaxoSmithKline, is funded with €3.5 million, of which €1.95 million goes to OncoMethylome and €1.55 million goes to the University of Liege.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.